246 related articles for article (PubMed ID: 31924363)
1. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
[TBL] [Abstract][Full Text] [Related]
3. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
Stokes SM; Massarweh NN; Stringham JR; Varghese TK
Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
[TBL] [Abstract][Full Text] [Related]
4. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
[No Abstract] [Full Text] [Related]
5. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
Odell DD; Feinglass J; Engelhardt K; Papastefan S; Meyerson SL; Bharat A; DeCamp MM; Bilimoria KY
J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1219-1235. PubMed ID: 31343410
[TBL] [Abstract][Full Text] [Related]
7. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
Nadpara P; Madhavan SS; Tworek C
Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
[TBL] [Abstract][Full Text] [Related]
8. Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.
Wakeam E; Giuliani M; Leighl NB; Finlayson SRG; Varghese TK; Darling GE
Ann Thorac Surg; 2017 May; 103(5):1647-1653. PubMed ID: 28267977
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
[TBL] [Abstract][Full Text] [Related]
11. Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
Collins ML; Mack SJ; Whitehorn GL; Till BM; Grenda TR; Evans NR; Gordon SW; Okusanya OT
Ann Thorac Surg; 2024 Mar; 117(3):568-575. PubMed ID: 37995842
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
13. Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.
Speicher PJ; Fitch ZW; Gulack BC; Yang CJ; Tong BC; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
Ann Thorac Surg; 2016 Sep; 102(3):884-894. PubMed ID: 27476819
[TBL] [Abstract][Full Text] [Related]
14. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
[TBL] [Abstract][Full Text] [Related]
16. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
17. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
Fan Q; Hussaini SMQ; Barrow LCJ; Feliciano JL; Pollack CE; Yabroff KR; Nogueira L
Cancer Med; 2024 Feb; 13(3):e6921. PubMed ID: 38205942
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
19. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
20. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
